| 12/5/2025 | BK | Stada wraps €2.26 billion term loan and £170 million term loan
|
| 10/1/2025 | HY | New Issue: Stada prices upsized €1.15 billion seven-year floaters at Euribor plus 325 bps at par
|
| 10/1/2025 | HY | Stada talks upsized €1.15 billion seven-year floating-rate notes at Euribor plus 325 bps at par
|
| 9/30/2025 | HY | Nidda Healthcare to sell €550 million seven-year secured floaters
|
| 9/30/2025 | BKHY | Moody's assigns B2 to Stada notes
|
| 9/29/2025 | HY | Germany’s Stada to sell €550 million seven-year floaters; initial talk Euribor plus 325-350 bps
|
| 5/27/2025 | BKHY | Moody's raises Nidda
|
| 4/29/2025 | HY | New Issue: Stada prices upsized €1.14 billion secured notes in two tranches
|
| 4/29/2025 | HY | Stada ups two-part notes offering to €1.14 billion, tightens talk; books close Tuesday
|
| 4/28/2025 | HY | Market Commentary: Euro primary returns to action; Saks plunges after investor call; Bausch strengthens
|
| 4/28/2025 | HY | Stada to price €965 million secured notes in fixed-, floating-rate tranches on Tuesday
|
| 10/10/2024 | HY | New Issue: Stada prices €1.25 billion of fixed-, floating-rate secured notes
|
| 10/9/2024 | BKHY | S&P rates Nidda Healthcare notes B
|
| 10/9/2024 | HY | Stada sets tranche sizes, final talk in €1.25 billion fixed-, floating-rate notes offering
|
| 10/8/2024 | BKHY | Moody’s rates Stada notes B3
|
| 10/8/2024 | HY | Stada sets initial talk on €1.25 billion fixed-, floating-rate notes
|
| 10/7/2024 | HY | Stada starts roadshow for €1.25 billion secured notes in fixed- and floating-rate tranches
|
| 6/28/2024 | BK | Stada changes minimum €500 million term loan B3 OID talk to 99.75-par
|
| 6/25/2024 | BKDDHY | S&P gives Nidda loan B
|
| 6/21/2024 | BKDDHY | Moody's assigns B3 to Nidda loan
|
| 6/18/2024 | BK | Stada to launch minimum €500 million term loan on Wednesday
|
| 6/16/2023 | BKDDHY | Moody’s changes Nidda view to positive
|
| 5/24/2023 | BKDDHY | Fitch assigns B+ to Nidda loan
|
| 5/4/2023 | BKDDHY | S&P assigns B to Nidda Healthcare loan
|
| 12/15/2022 | BKDDHY | Moody’s snips Stada loans
|
| 10/13/2022 | BKDDHY | Fitch rates Nidda Healthcare exchange notes B+
|
| 9/21/2021 | BK | Stada firms terms on €295 million, £50 million add-on term loans
|
| 9/15/2021 | BK | Stada to launch €350 million equivalent add-on term loan on Thursday
|
| 1/31/2020 | HY | New Issue: Nidda sells €350 million add on to 3½% notes due 2024 at 101
|
| 1/27/2020 | BKDDHY | Fitch rates Nidda debt B+
|
| 12/2/2019 | BKHY | Fitch gives Nidda BondCo debt B+
|
| 11/30/2018 | HY | Market Commentary: Europe sees one deal withdraw; Mercer weakens; energy slump continues, Altice gains
|
| 11/30/2018 | BKCVDDEMIGPV | Market Commentary: Europe sees one deal withdraw; Mercer weakens; energy slump continues, Altice gains
|
| 11/30/2018 | HY | New Issue: Nidda sells €250 million 7¼% seven-year notes to yield 7¾%
|
| 11/29/2018 | HY | Market Commentary: Mercer prices; McDermott rebound continues; Westcorp drops; Bausch improves; funds lose $1.2 billion
|
| 11/29/2018 | HY | Nidda Healthcare talks €250 million seven-year notes at 7¾% area; pricing Friday
|
| 11/15/2018 | BKHY | S&P changes Nidda view to negative
|
| 10/31/2018 | BKHY | Fitch puts Nidda on watch
|
| 7/26/2018 | BKHY | Fitch rates Nidda loan BB-, notes BB-, B-
|
| 6/29/2018 | HYLM | Stada tenders for 1¾% notes due 2022 ahead of holders’ meeting
|
| 11/21/2017 | HYLM | Stada Arzneimittel 1¾%, 2¼% notes putable after acquisition by Nidda
|
